& Kemona, H
Interim glycaemic assessment should use fasting plasma glucose, OGTT, or self-monitored blood glucose
Adding AOD 9604 targeted fat breakdown may shift this ratio even further toward preferential fat loss, though controlled studies of the combination are limited
The 5mg dose offers 5 times the strength of the 1mg
WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
Timeline & Results 1 Week vs 1 Month (Before-and-After Expectations) Most before & after stories pair injections with a calorie deficit, protein targets, training, steps, and sleep